QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Market-Moving News for April 25th
04/25/2024 12:31:16

ULBI: 26% | Ultralife shares are trading higher after the company reported better-than-expected Q1 financial results.CDTX: 41% ...

 optinose-provides-corporate-updates-expects-to-produce-positive-income-from-operations-for-full-year-2025

In addition, the Company announced preliminary XHANCE net product revenue of $14.9 million for the three months ended March 31,...

 lake-street-maintains-buy-on-optinose-raises-price-target-to-4

Lake Street analyst Thomas Flaten maintains OptiNose (NASDAQ:OPTN) with a Buy and raises the price target from $3 to $4.

 hc-wainwright--co-reiterates-buy-on-optinose-maintains-5-price-target

HC Wainwright & Co. analyst Matthew Caufield reiterates OptiNose (NASDAQ:OPTN) with a Buy and maintains $5 price target.

 optinose-shares-resume-trade
OptiNose Shares Resume Trade
03/15/2024 20:20:46

 hc-wainwright--co-initiates-coverage-on-optinose-with-buy-rating-announces-price-target-of-5

HC Wainwright & Co. analyst Matthew Caufield initiates coverage on OptiNose (NASDAQ:OPTN) with a Buy rating and announce...

 optinose-q4-gaap-eps-009-inline-sales-1986m-beat-1923m-estimate

OptiNose (NASDAQ:OPTN) reported quarterly losses of $(0.09) per share which met the analyst consensus estimate. This is a 47.06...

 earnings-scheduled-for-march-7-2024

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

 optinoses-earnings-a-preview
OptiNose's Earnings: A Preview
03/06/2024 19:01:30

 optinose-announces-the-publication-of-reopen-phase-3-clinical-trial-program-evaluating-xhance-in-the-journal-of-allergy-and-clinical-immunology-in-practice

XHANCE significantly reduced both symptoms and sinus opacification in participants with chronic sinusitis (chronic rhinosinusit...

 gold-moves-higher-campbell-soup-earnings-top-expectations

U.S. stocks traded mixed toward the end of trading on Wednesday. The Dow traded up 0.05% to 36,143.40 while the NASDAQ fell 0....

 why-aerovironment-shares-are-trading-lower-by-over-9-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION